» Articles » PMID: 37576285

Severity-onset Prediction of COVID-19 Via Artificial-intelligence Analysis of Multivariate Factors

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Aug 14
PMID 37576285
Authors
Affiliations
Soon will be listed here.
Abstract

Progression to a severe condition remains a major risk factor for the COVID-19 mortality. Robust models that predict the onset of severe COVID-19 are urgently required to support sensitive decisions regarding patients and their treatments. In this study, we developed a multivariate survival model based on early-stage CT images and other physiological indicators and biomarkers using artificial-intelligence analysis to assess the risk of severe COVID-19 onset. We retrospectively enrolled 338 adult patients admitted to a hospital in China (severity rate, 31.9%; mortality rate, 0.9%). The physiological and pathological characteristics of the patients with severe and non-severe outcomes were compared. Age, body mass index, fever symptoms upon admission, coexisting hypertension, and diabetes were the risk factors for severe progression. Compared with the non-severe group, the severe group demonstrated abnormalities in biomarkers indicating organ function, inflammatory responses, blood oxygen, and coagulation function at an early stage. In addition, by integrating the intuitive CT images, the multivariable survival model showed significantly improved performance in predicting the onset of severe disease (mean time-dependent area under the curve = 0.880). Multivariate survival models based on early-stage CT images and other physiological indicators and biomarkers have shown high potential for predicting the onset of severe COVID-19.

Citing Articles

Association between Vaccination Status for COVID-19 and the Risk of Severe Symptoms during the Endemic Phase of the Disease.

Mendoza-Cano O, Trujillo X, Rios-Silva M, Lugo-Radillo A, Benites-Godinez V, Bricio-Barrios J Vaccines (Basel). 2023; 11(10).

PMID: 37896916 PMC: 10610663. DOI: 10.3390/vaccines11101512.

References
1.
Geskus R . Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2010; 67(1):39-49. DOI: 10.1111/j.1541-0420.2010.01420.x. View

2.
Rueda O, Sammut S, Seoane J, Chin S, Caswell-Jin J, Callari M . Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. Nature. 2019; 567(7748):399-404. PMC: 6647838. DOI: 10.1038/s41586-019-1007-8. View

3.
van Rij R, de Roda Husman A, Brouwer M, Goudsmit J, Coutinho R, Schuitemaker H . Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis. 1998; 178(6):1806-11. DOI: 10.1086/314522. View

4.
Wang X, Zhang H, Du H, Ma R, Nan Y, Zhang T . Risk Factors for COVID-19 in Patients with Hypertension. Can J Infect Dis Med Microbiol. 2021; 2021:5515941. PMC: 8112195. DOI: 10.1155/2021/5515941. View

5.
van der Walt S, Schonberger J, Nunez-Iglesias J, Boulogne F, Warner J, Yager N . scikit-image: image processing in Python. PeerJ. 2014; 2:e453. PMC: 4081273. DOI: 10.7717/peerj.453. View